TNF-Receptor Inhibitor Therapy for the Treatment of Children with Idiopathic Pneumonia Syndrome. A Joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521)-Reference-Cited by-同舟云学术

TNF-Receptor Inhibitor Therapy for the Treatment of Children with Idiopathic Pneumonia Syndrome. A Joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521)

Published:2015-01 Issue:1 Volume:21 Page:67-73
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Yanik Gregory A.,Grupp Stephan A.,Pulsipher Michael A.,Levine John E.,Schultz Kirk R.,Wall Donna A.,Langholz Bryan,Dvorak Christopher C.,Alangaden Keith,Goyal Rakesh K.,White Eric S.,Collura Jennifer M.,Skeens Micah A.,Eid Saada,Pierce Elizabeth M.,Cooke Kenneth R.

Funder

Leukemia and Lymphoma Society

Burroughs Welcome Fund

St. Baldrick's Foundation

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference35 articles.

1. Idiopathic pneumonia syndrome: Changing spectrum of lung injury after marrow transplantation;Kantrow;Transplantation,1997

2. Clinical course of idiopathic pneumonia after bone marrow transplantation;Crawford;Am Rev Respir Dis,1993

3. Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation;Yanik;Biol Blood Marrow Transplant,2002